HORSHAM, Pa.--(BUSINESS WIRE)--Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & Distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA.

宾夕法尼亚州霍沙姆（商业新闻短讯）--全球领先的临床试验供应公司Myonex已与Creapharm Group的所有者达成协议，收购Creapharm临床包装与分销以及商业包装业务和生物服务，总部位于法国兰斯，另外在法国波尔多和贝利-罗曼维利尔斯以及美国乔治亚州马里埃塔。

The completion of this transaction is subject to regulatory approvals.

该交易的完成须经监管部门批准。

This strategic acquisition will bring complementary strengths to the marketplace. Myonex is the market leader in drug sourcing and clinical trial prescription services with growing franchises in clinical packaging, labeling and distribution, and ancillary equipment and supply. Creapharm will bring scale and deep expertise in clinical packaging and distribution alongside existing franchises in commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management.

此次战略性收购将为市场带来互补优势。Myonex是药物采购和临床试验处方服务的市场领导者，在临床包装、标签和分销以及辅助设备和供应方面拥有越来越多的特许经营权。Creapharm将带来临床包装和分销方面的规模和深度专业知识，以及商业包装和高级治疗药品（ATMPs）供应链管理方面的现有特许经营权。

“By combining, we will fill a gap in the market with broad and deep expertise, integrated services, and extraordinary client focus,” said James Lovett, CEO of Myonex. “Myonex looks forward to combining with our Creapharm colleagues to meet the needs of our clients with agility and speed.”

Myonex首席执行官詹姆斯·洛维特（JamesLovett）表示：“通过合并，我们将以广泛而深入的专业知识、综合服务和非凡的客户关注填补市场空白。”。“Myonex期待与Creapharm的同事合作，以灵活快速的方式满足客户的需求。”

“Growing with Myonex is an obvious step for Creapharm to move forward, contributing our expertise and wide range of packaging solutions to their operations while we will expand the range of services we offer in support of always more effective, efficient, patient-centric clinical trials,” said Eric Placet, Creapharm’s CEO and Founder.

Creapharm首席执行官兼创始人Eric Placet表示：“与Myonex一起发展是Creapharm向前迈出的明显一步，为其运营贡献了我们的专业知识和广泛的包装解决方案，同时我们将扩大我们提供的服务范围，以支持始终更有效，更高效，以患者为中心的临床试验。”

“Creapharm is pleased to evolve the overall mission of Myonex through our complementary strengths and to provide scale and flexibility in meeting our clients’ needs.”

“Creapharm很高兴通过我们的互补优势发展Myonex的整体使命，并在满足客户需求方面提供规模和灵活性。”

“We have complementary strengths and cultural alignment that make this an exciting solution for the industry, our colleagues and clients,” said Michael Cohen, Myonex’s Co-Owner, and Executive Chairman. “We share traditions of entrepreneurship and engagement with team members, as well as a commitment to social and environmental responsibility to ensure the success of our clients, clinical trial sites and patients.”

Myonex的共同所有者兼执行主席迈克尔·科恩（MichaelCohen）表示：“我们拥有互补的优势和文化一致性，这使它成为业界、同事和客户的令人兴奋的解决方案。”“我们与团队成员分享创业和参与的传统，并承诺承担社会和环境责任，以确保我们的客户，临床试验地点和患者取得成功。”

Conditional upon the successful completion of the transaction, Mike Cohen will continue as Executive Chairman and James Lovett as CEO of the combined company. Eric Placet will reinvest into Myonex as well as join Myonex’s Board of Directors further solidifying the relationship. Creapharm’s Carla Da Costa will join the combined management teams and Edouard Placet will also have a strategic and leadership role in the combined company.

如果交易成功完成，迈克·科恩（MikeCohen）将继续担任执行董事长，詹姆斯·洛维特（JamesLovett）将继续担任合并公司的首席执行官。埃里克·普莱塞特（EricPlacet）将重新投资Myonex，并加入Myonex董事会，进一步巩固这种关系。Creapharm的Carla Da Costa将加入合并管理团队，Edouard Placet也将在合并后的公司中发挥战略和领导作用。

About Myonex

关于Myonex

Myonex is a leading global clinical trial supply company offering tailored solutions in drug sourcing, packaging & labeling, equipment & supplies, and market leading CTRx solution for each trial’s specific requirements and complexities. With our locations in the US, EU, and UK we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), and other clinical trial service providers seeking a flexible, comprehensive solution for their trial supply needs.

Myonex是一家领先的全球临床试验供应公司，针对每个试验的具体要求和复杂性，在药物采购、包装和标签、设备和用品以及市场领先的CTRx解决方案方面提供量身定制的解决方案。我们位于美国、欧盟和英国，与制药和生物技术公司、合同研究组织（CRO）和其他临床试验服务提供商合作，寻求灵活、全面的解决方案来满足其试验供应需求。

About Creapharm

关于Creapharm

With decades of experience in global clinical trial supply management, Creapharm supports Pharma and Biotech key players with customized solutions. Creapharm has a strong expertise in cold-chain management and recently developed ultra-cold solutions to handle biologicals and ATMP supply chain management.

凭借数十年的全球临床试验供应管理经验，Creapharm为制药和生物技术的关键参与者提供定制解决方案。Creapharm在冷链管理方面拥有丰富的专业知识，最近开发了超冷解决方案来处理生物制品和ATMP供应链管理。

For marketed health products, Creapharm offers expert commercial packaging services to pharmaceutical and food supplement industries.

对于上市的健康产品，Creapharm为制药和食品补充行业提供专业的商业包装服务。